JAK2 and essential thrombocythemia: The diagnostic criteria for ET have been announced to be platelet count ≥450 × 109/L, a proliferative bone marrow appearance with megakaryocyte predominance, not meeting the criteria for other myeloid neoplasms, and presence of a JAK2, CALR, or MPL mutation, by the World Health Organization (WHO) [152].